Acute cathinone poisoning: epidemiology, pathogenesis, clinical picture, diagnosis and treatment principles (literature review)
- 作者: Makarovskaya N.P.1,2, Lodyagin A.N.1, Batotsyrenov B.V.1, Balabanova O.L.1,3, Evdokimova E.A.4
-
隶属关系:
- State Budgetary Institution “St. Petersburg Scientific Research Institute of Emergency Medicine named after I.I. Dzhanelidze”
- Federal State Budgetary Educational Institution of Higher Education “I.P. Pavlov First Saint Petersburg State Medical University” of the Ministry of Health of the Russian Federation
- Federal State Budgetary Educational Institution of Higher Education “Saint Petersburg State Chemical and Pharmaceutical University” of the Ministry of Health of the Russian Federation
- Federal State Budgetary Institution "Scientific and Clinical Center of Toxicology named after Academician S.N. Golikov" of the Federal Medical and Biological Agency
- 期: 编号 1 (2025)
- 页面: 39-49
- 栏目: Clinical toxicology
- ##submission.datePublished##: 15.02.2025
- URL: https://gynecology.orscience.ru/0869-7922/article/view/659796
- DOI: https://doi.org/10.47470/0869-7922-2025-33-1-39-49
- EDN: https://elibrary.ru/pvzozh
- ID: 659796
如何引用文章
详细
Introduction. Acute poisoning with modern psychoactive substances and narcotic drugs is today among the main reasons for emergency hospitalization of people with acute poisoning.
Material and methods. The work summarizes information about epidemiology, pathogenesis, clinical picture, as well as diagnosis and principles of treatment of patients with acute cathinone poisoning.
Results. Cathinones are synthetic drugs that are similar in a number of ways, including their structure and mechanism of action to amphetamines and are used as psychoactive substances. The circulation of synthetic cathinones is under the control of the international community. Synthetic cathinones continue to hold the lead both in the number of new modifications created and in the volume of illegal trafficking, which drug control authorities are trying to suppress both in Russia and in neighboring countries. The class of synthetic cathinones today is quite numerous, although among users of surfactants their popularity varies, with the presence of clearly defined “market leaders”. These compounds may be substrates for presynaptic monoamine transporters (dopamine transporter, norepinephrine transporter, and serotonin transporter). Transporters responsible for reuptake of released monoamines from the synaptic cleft into the presynaptic neuron may be able to terminate the action of that monoamine at the postsynaptic receptor and facilitate recycling of the monoamine for re-release. In acute poisoning with cathinones, the clinical picture is nonspecific. It may manifest itself in the form of psychomotor agitation and/or hallucinations. In more severe cases, there are violations of life support systems. To determine α-PVP in biological objects (blood, urine, hair, nail sections), gas and liquid chromatography-mass spectrometry is usually used. Treatment of cathinone poisoning includes maintaining vital body functions: restoring hemodynamics, correcting electrolyte balance and relieving mental symptoms.
Limitations. The study was conducted by studying the databases Scopus, Web of Science, PubMed, Russian Science Citation Index, eLIBRARY, Cyberleninka.
Conclusion. A literature review of acute cathinone poisoning allows us to become familiar with the current problem of abuse of synthetic stimulants of the central nervous system. Studying the mechanisms of action, clinical manifestations, treatment and prevention allows us to form more informed approaches to this problem and develop effective measures to prevent and solve it.
Authors contribution:
Makarovskaya N.P. – the concept and design of research, writing the text;
Batotsyrenov B.V., Balabanova O.L., Evdokimova E.A. – collection and processing of materials;
Lodyagin A.N. – responsibility for the integrity of all parts of the article, writing the text.
All co-authors – approval of the final version of the article.
Conflict of interests. The authors declare no conflict of interest.
Funding. The study had no sponsorship.
Received: August 08, 2024 / Revised: August 28, 2024 / Accepted: December 18, 2024 / Published: February 25, 2025
作者简介
Natalia Makarovskaya
State Budgetary Institution “St. Petersburg Scientific Research Institute of Emergency Medicine named after I.I. Dzhanelidze”; Federal State Budgetary Educational Institution of Higher Education “I.P. Pavlov First Saint Petersburg State Medical University” of the Ministry of Health of the Russian Federation
Email: kostromica@gmail.com
ORCID iD: 0009-0005-6113-9860
Doctor of Anesthesiology and Resuscitation, Toxicologist, Postgraduate Student of the Department of Emergency Care and Surgery of Injuries I.P. Pavlov First Saint Petersburg State Medical University, 197022, Saint-Petersburg, Russian Federation
e-mail: kostromica@gmail.com
Alexey Lodyagin
State Budgetary Institution “St. Petersburg Scientific Research Institute of Emergency Medicine named after I.I. Dzhanelidze”
Email: alodyagin@mail.ru
ORCID iD: 0000-0002-8672-2906
Doctor of Medical Sciences, Associate Professor, Head of the Department of Clinical Toxicology of the I.I. Janelidze Research Institute of Emergency Medicine, 192242, Saint-Petersburg, Russian Federation
e-mail: alodyagin@mail.ru
Bair Batotsyrenov
State Budgetary Institution “St. Petersburg Scientific Research Institute of Emergency Medicine named after I.I. Dzhanelidze”
Email: bbair@mail.ru
ORCID iD: 0000-0003-4954-8977
Doctor of Medical Sciences, Associate Professor, Chief Researcher of the Department of Clinical Toxicology of the I.I. Janelidze Research Institute of Emergency Medicine, 192242, Saint-Petersburg, Russian Federation
e-mail: bbair@mail.ru
Olga Balabanova
State Budgetary Institution “St. Petersburg Scientific Research Institute of Emergency Medicine named after I.I. Dzhanelidze”; Federal State Budgetary Educational Institution of Higher Education “Saint Petersburg State Chemical and Pharmaceutical University” of the Ministry of Health of the Russian Federation
Email: o.l.ya@mail.ru
ORCID iD: 0000-0002-8636-9858
Head of the Chemical and Toxicological Laboratory of Clinical Toxicology of the I.I. Janelidze Research Institute of Emergency Medicine, 192242, Saint-Petersburg, Russian Federation; lecturer at the Department of Pharmaceutical Chemistry of the St. Petersburg State University of Chemistry and Pharmacy of the Ministry of Health of the Russian Federation, 197376, Saint-Petersburg, Russian Federation
e-mail: o.l.ya@mail.ru
Ekaterina Evdokimova
Federal State Budgetary Institution "Scientific and Clinical Center of Toxicology named after Academician S.N. Golikov" of the Federal Medical and Biological Agency
编辑信件的主要联系方式.
Email: innova.2000@mail.ru
ORCID iD: 0009-0001-6759-526X
Research associate of Federal State Budgetary Institution "Scientific and Clinical Center of Toxicology named after Academician S.N. Golikov" of the Federal Medical and Biological Agency, 192242, Saint-Petersburg, Russian Federation
e-mail: innova.2000@mail.ru
参考
- Shikalova I.A., Lodyagin A.N., Barsukova I.M., Panov A.M., Sinenchenko A.G. The role of the toxicological service in the drug situation monitoring system: problems and ways of improvement. Toksikologicheskiy vestnik (Toxicological Review). 2023; 31(3): 142–9. https://doi.org/10.47470/0869-7922-2023-31-3-142-149 (in Russian)
- Golovko A.I., et al. Designer drugs. Classifications, mechanisms of toxicity. Narcologiya. 2015; 14 (8):164? 69–85. (in Russian)
- The European Monitoring Centre for Drugs and Drug Addiction (2018). Available at: https://www.emcdda.europa. eu/emcdda-home-page_en (accessed May 30, 2024).
- Terminology and information on narcotic drugs [Terminologiya I informatsiya po narkoticheskim sredstvam OON]. UN, 3rd edition, 2016. (in Russian)
- Cathinones in Europe: An update. Publications Office of the European Union, EMCDDA, Luxembourg; 2015.
- Balabanova O.L. et al. Structure and laboratory diagnostics of non-medical use of modern synthetic drugs. Zhurnal im. N.V. Sklifosovskogo "Neotlozhnaya medicinskaya pomoshh`". 2019; 8(3): 315–9.
- Wander A. α-Pyrrolidinovalerophenones; British Patent 403 GB927475; Bern, Switzerland; 1963.
- European Monitoring Centre for Drugs and Drug Addiction. EMCDDA-Europol. Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP), in the framework of the Council Decision on new psychoactive substances -2016. Availble at: https://euda.europa.eu/system/files/publications/2934/TDAK16001ENN.pdf (Accessed July 10, 2024)
- Zawilska J.B., Wojcieszak J. α-Pyrrolidinophenones: a new wave of designer cathinones. Forensic Toxicology. 2017; 35: 201–16.
- Amanollahi A., et al. Incidence of rhabdomyolysis occurrence in psychoactive substances intoxication: a systematic review and meta-analysis. Scientific Reports. 2023; 13(1): 17693.
- Banks M.L., Worst T.J., Rusyniak D.E., Sprague J.E. Synthetic cathinones (“bath salts”). The Journal of emergency medicine. 2014; 46(5): 632–42. https://doi.org/10.1016/j.jemermed.2013.11.104
- Rothman R.B., et al. Amphetamine‐type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. 2001; 39 (1): 32–41.
- Patel K., et al. Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Therapeutic advances in psychopharmacology. 2016; 6(2): 99–144.
- Hondebrink L., Zwartsen A., Westerink R.H.S. Effect fingerprinting of new psychoactive substances (NPS): What can we learn from in vitro data? Pharmacology & therapeutics. 2018; 182: 193–224.
- Riley A.L., et al. Abuse potential and toxicity of the synthetic cathinones (ie,“Bath salts”). Neuroscience & Biobehavioral Reviews. 2020; 110: 150–73.
- Torres P.A., et al. Rhabdomyolysis: pathogenesis, diagnosis, and treatment. Ochsner Journal. 2015; 15(1): 58–69.
- Cervellin G., Comelli I., Lippi G. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clinical chemistry and laboratory medicine. 2010; 48(6): 749–56.
- Petejova N., Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Critical Care. 2014; 18(3): 1–8.
- Zaikina O.L., Shilov V.V., Lodyagin A.N. Determination of the structures of free and glucuronidated metabolites of α-pyrrolidinovalerophenone in human urine by liquid chromatography-mass spectrometry for accurate mass measurement. Zhurnal analiticheskoj himii. 2019; 74(5): 381–96. (in Russian)
- Grapp M., et al. GC–MS analysis of the designer drug α-pyrrolidinovalerophenone and its metabolites in urine and blood in an acute poisoning case. Forensic science international. 2016; 259: e14-9.
- Haas C. et al. Studies on the metabolism and toxicological analysis of the new designer drug alpha-Pyrrolidino-valerophenone (PVP) in rat urine using GC-MS techniques. Current Contributions to Forensic and Clinical Toxicology. 2008; 269: 1–7.
- Larabi I.A., et al. Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs: A cross sectional study by hair testing (2012–2017). Drug and alcohol dependence. 2019; 204: 107508.
- Federal clinical guidelines “Poisoning with drugs and psychodysleptics” [Federal`ny`e klinicheskie rekomendacii "Otravleniya narkotikami i psihodisleptikami"]. Moscow; 2018. (in Russian)
- Sinenchenko A.G., et al. Analysis of the structure of acute poisoning with modern psychoactive substances. Gygiena i Sanitariya. 2020; 99(6): 569–74. (in Russian)
补充文件
